These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350 [TBL] [Abstract][Full Text] [Related]
4. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Jeppesen J; Zhou MY; Chen YD; Reaven GM Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127 [TBL] [Abstract][Full Text] [Related]
5. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes. Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815 [TBL] [Abstract][Full Text] [Related]
7. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue. Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908 [TBL] [Abstract][Full Text] [Related]
8. The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM). Elkeles RS Diabete Metab; 1991 May; 17(1 Pt 2):197-200. PubMed ID: 1936476 [TBL] [Abstract][Full Text] [Related]
9. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients. Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888 [TBL] [Abstract][Full Text] [Related]
10. Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus. Reaven GM Am J Med; 1983 Nov; 75(5B):8-14. PubMed ID: 6369970 [TBL] [Abstract][Full Text] [Related]
11. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients. Yu JG; Kruszynska YT; Mulford MI; Olefsky JM Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431 [TBL] [Abstract][Full Text] [Related]
12. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Abbasi F; Carantoni M; Chen YD; Reaven GM Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437 [TBL] [Abstract][Full Text] [Related]
13. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin. Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. Fantus IG; Brosseau R J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404 [TBL] [Abstract][Full Text] [Related]
16. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. DeFronzo RA; Barzilai N; Simonson DC J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512 [TBL] [Abstract][Full Text] [Related]
18. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin. Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381 [TBL] [Abstract][Full Text] [Related]
20. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]